Melanoma
From the Journals
RCC strongly linked to melanoma, and vice versa
Clinicians need to be vigilant for RCCs in melanoma patients, and for melanomas in RCC patients.
Community Translations
BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
Conference Coverage
A novel tracer shows promise for detecting CD8 T-cells in advanced solid tumors
WASHINGTON – PET with 89Zr-IAB22M2C provides detailed information on CD8 T-cell biodistribution in patients with advanced solid tumors...
From the Journals
Second-melanoma risk higher with indoor tanning
Tanning-bed users also had less time before the diagnosis of their second tumor.
From the Journals
SRS beats surgery in early control of brain mets, advantage fades with time
Patients undergoing complete surgical resection for brain mets were at much higher risk of local recurrence than patients.
From the Journals
Circulating tumor DNA identified by fragment size
Circulating tumor DNA in plasma is more likely to be within certain fragment size ranges, which could enable its detection and use in cancer...
Conference Coverage
Nivo + ipi shows durable activity against metastatic melanoma
MUNICH – Four-year data from the Checkmate 067 study bolster earlier findings supporting the checkpoint inhibitor combination in first line...
From the Journals
Checkpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanoma
The 3-year overall survival rate for patients treated with nivolumab was 51.2%, compared with 21.6% for those who received dacarbazine.
Conference Coverage
Checkpoint inhibitor seems safe and effective for patients with HIV
MUNICH – No immune-related adverse events or deaths due to drug toxicity occurred in cancer patients with HIV treated with nivolumab.
From the Journals
Epacadostat plus pembrolizumab shows promise in advanced solid tumors
Investigational drug epacadostat plus pembrolizumab demonstrated promising antitumor activity and safety in patients with advanced solid tumors....
From the Journals
Checkpoint inhibitor linked to antiphospholipid syndrome in melanoma patient
A melanoma patient receiving pembrolizumab was diagnosed with antiphospholipid syndrome that resolved following discontinuation of that treatment...